Serving hundreds of leading biopharmaceutical companies globally:

Generated: January 16, 2019

DrugPatentWatch Database Preview

Darbepoetin alfa - Biologic Drug Details

« Back to Dashboard

Summary for darbepoetin alfa

Tradenames:	1
Patents:	70
Applicants:	1
BLAs:	1
Suppliers: see list	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for darbepoetin alfa

Pharmacology for darbepoetin alfa

Ingredient-type	Erythropoietin
Physiological Effect	Increased Erythroid Cell Production

US Patents for darbepoetin alfa

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Amgen	ARANESP	darbepoetin alfa	VIAL; INTRAVENOUS	103951	001	2001-09-17	➤ Sign Up	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	➤ Sign Up	RX		search
Amgen	ARANESP	darbepoetin alfa	VIAL; INTRAVENOUS	103951	001	2001-09-17	➤ Sign Up		➤ Sign Up	RX		search
Amgen	ARANESP	darbepoetin alfa	VIAL; INTRAVENOUS	103951	001	2001-09-17	➤ Sign Up		➤ Sign Up	RX		search
Amgen	ARANESP	darbepoetin alfa	VIAL; INTRAVENOUS	103951	001	2001-09-17	➤ Sign Up	YALE UNIVERSITY (New Haven, CT)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for darbepoetin alfa

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Austria	551422	➤ Sign Up
Brazil	PI0718966	➤ Sign Up
Croatia	P20161763	➤ Sign Up
Mexico	PA06012394	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for darbepoetin alfa

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0075	Netherlands	➤ Sign Up	PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608
/2001	Austria	➤ Sign Up	PRODUCT NAME: DARBEPOETIN-ALFA; REGISTRATION NO/DATE: EU/1/01/185/001-030 20010608
2004015	Lithuania	➤ Sign Up	PRODUCT NAME: DARBEPOETINAS ALFA (ASN30 THR32 VAL87 ASN88 THR90 EPO); REGISTRATION NO/DATE: EU/1/01/185/001-030 20010608
C0050	France	➤ Sign Up	PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo

Express Scripts

Merck

Julphar

Fuji

Argus Health

Federal Trade Commission

Cantor Fitzgerald

UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.